Headline News about Amicus Therapeutics![]() ![]() ![]() ![]() ![]()
The Analyst Landscape: 4 Takes On Amicus Therapeutics
December 19, 2023
Via Benzinga
![]()
Amicus Therapeutics: Q1 Earnings Insights
May 10, 2023
Via Benzinga
![]()
The Latest Analyst Ratings for Amicus Therapeutics
March 28, 2023
Via Benzinga
![]() ![]()
Earnings Preview: Amicus Therapeutics
February 28, 2023
Via Benzinga
![]() ![]() ![]() ![]() ![]() ![]() Via Benzinga
![]() ![]() ![]() ![]() ![]() ![]() ![]() Via Benzinga
![]() Via Benzinga
![]()
Benzinga's Top Ratings Upgrades, Downgrades For September 9, 2022
September 09, 2022
Via Benzinga
![]() ![]() ![]() ![]()
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|
Kelownadailycourier.ca
Phone number: (250) 763-4000
E-mail: csr@ok.bc.ca
Address: 550 Doyle Avenue
Kelowna, BC V1Y 7V1
© Copyright 2015, Daily Courier, Kelowna, BC. Powered by BLOX Content Management System from TownNews.com.